ArticleOPEN ACCESS

Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma

British Journal of Haematology
DOI: 10.1111/bjh.15156
76Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Castillo, J. J., Guerrero-Garcia, T., Baldini, F., Tchernonog, E., Cartron, G., Ninkovic, S., … Bibas, M. (2019, February 1). Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. British Journal of Haematology. Blackwell Publishing Ltd. https://doi.org/10.1111/bjh.15156

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free